This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Demeclocycline

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Demeclocycline is a tetracyline drug used in the treatment of hyponatraemia caused by syndrome of inappropriate ADH secretion, where fluid restriction has not been effective.

It may act to directly block the action of ADH on the tubule; in doing so it effectively causes a nephrogenic diabetes insipidus.

Side effects include diabetes insipidus and a photosensitive rash.

Demeclocycline can cause reversible azotaemia and sometimes nephrotoxicity, especially in patients with cirrhosis

Reference:

  • (1) hyponatraemia Treatment Guidelines 2007: Expert Panel Recommendations.American Journal of Medicine 2007; 120 (11);S1:S1-S21.

 


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.